Company Overview and News

0
MGTA / Magenta Therapeutics, Inc. 8-K (Current Report)

2018-08-09 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
MGTA

0
MGTA / Magenta Therapeutics, Inc. 10-Q (Quarterly Report)

2018-08-09 sec.gov
10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION
MGTA

4
Magenta Therapeutics: Developing Novel Treatments In Hematopoietic Stem Cell Transplants

2018-07-23 seekingalpha
The current market cap of the company is about $488M which is low considering the large target markets its product candidates are addressing (reaching in multi-billions USD per year).
MGTA GSK

68
6 Speculative BioHealth Analyst Stocks That Could Rally 50% to 300%

2018-07-21 247wallst
The bull market is now more than nine years old. Many investors have begun looking for new ideas and new strategies to generate income and gains, and the old strategy of buying every major market selling day has become less rewarding in 2018 versus the prior few years. It turns out that Wall Street brokerages and research shops still have many stock picks for big upside.
EIDX MGTA INNT GLMD RARX SNDX

0
MGTA / Magenta Therapeutics, Inc. null

2018-07-20 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$S(# @;V)J#3P\+TQI;F5A
MGTA

0
MGTA / Magenta Therapeutics, Inc. null

2018-07-20 sec.gov
DRSLTR May 7, 2018 Irene Paik Ada D. Sarmento Office of Healthcare and Insurance Division of Corporation Finance
MGTA

0
MGTA / Magenta Therapeutics, Inc. null

2018-07-20 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"[email protected],"!O8FH-/#PO3&EN96%R:7IE9" [email protected],S,X M-SDO3R Q,2]%(#(X,[email protected],B]4(#,[email protected][email protected]@6R [email protected],30Y73X^#65N M9&]B:@[email protected](" @(" @(" @(" @(" @(" @#0HQ-B P(&]B:@T\/"]$96-O9&50 M87)M7!E+UA2968O5ULQ(#(@,5T^/G-T
MGTA

0
MGTA / Magenta Therapeutics, Inc. null

2018-07-20 sec.gov
CORRESP May 24, 2018 Irene Paik Ada D. Sarmento Office of Healthcare and Insurance Division of Corporation Finance
MGTA

0
MGTA / Magenta Therapeutics, Inc. null

2018-07-20 sec.gov
CORRESP CONFIDENTIAL TREATMENT REQUESTED BY MAGENTA THERAPEUTICS, INC. MGTA-0001 Goodwin Procter LLP 100 Northern Avenue
MGTA

0
MGTA / Magenta Therapeutics, Inc. null

2018-07-20 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4*)>+CS],*,2 P(&]B:@H\/"]4>7!E+UA/8FIE8W0O0V]L;W)3 M<&%C92]$979I8V5'
MGTA

0
MGTA / Magenta Therapeutics, Inc. null

2018-07-20 sec.gov
CORRESP June 8, 2018 Irene Paik Ada D. Sarmento Office of Healthcare and Insurance Division of Corporation Finance
MGTA

0
MGTA / Magenta Therapeutics, Inc. null

2018-07-20 sec.gov
CORRESP Magenta Therapeutics, Inc. 50 Hampshire Street, 8th Floor Cambridge, MA 02139 VIA EDGAR AND FACSIMILE
MGTA

0
MGTA / Magenta Therapeutics, Inc. null

2018-07-20 sec.gov
CORRESP June 18, 2018 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E.
MGTA

0
Magenta Therapeutics started at overweight with $18 stock price target at J.P. Morgan

2018-07-16 marketwatch
Your Daily Pharma Scoop: Review Of 3 Stocks From The Biotech Boom IPO Week (18 - 22 June)
MGTA

285
Stocks To Watch: Prime Time In Retail

2018-07-14 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
ECOR PLNT PKG AEP NINE ADT GE COF-P GILD TMUS PDYPF SYF XERS JNJ VZ MSFT ADS KZR NNN EIDX FB AVRO HOPE NFLX AXP EHC BAC COF-D SEAS COF-C COF-F KR KS IIIV PNFP AAPL DDOC SJM INPAP SIX JPM GNE WRK LGEJY KMRFZ DE 39IB KMX RF UAL WMT CFIN LGEAF IP AMZN MGTA NTRS HON KMI CIWV HCSG KMR CVB VLKAY LGEIY EBAY EPRT STT SLB BAC DFS LGEPF STM BBY BX BK STM LTXB LGLD SLB FOXA CLW PM NTRSP AUTL DLPH SWKS GS SWK TRTX GM PII DIS NEE IBM MOR F GEC C CMCSA COF FUN FUL CFG HBAN XEL TGT BLK S PPG T SNE DPZ

Related Articles

RNVA: Rennova Health Analysis and Research Report

4h - Asif

Business overview Rennova Health, Inc. (together with its subsidiaries, “Rennova”, “we” or the “Company”) is a provider of an expanding group of health care services for healthcare providers, patients and individuals. Beginning in 2018, the Company intends to focus on and operate two synergistic divisions: 1) Clinical diagnostics through its clinical laboratories; and 2) Hospital operations through its Big South Fork Medical Center, which opened on August 8, 2017, and a hospital in Jamestown Tennessee, including a doctor’s practice, the assets of which the company expect to acquire in the second quarter of 2018, pursuant to the terms of a definitive asset purchase agreement that the company entered into on January 31, 2018, as more fully discussed below. The company believe that its approach will produce a more sustainable business model and the capture of multiple revenue streams from medical providers, patients and hospital services. Management determined that because Big So...

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

CUSIP: 55910K108